Ammon S et al. |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848660
|
Leiper K et al. |
Open label trial of oral clarithromycin in active Crohn's disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848665
|
Dalla Libera M et al. |
High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8730251
|
Labenz J et al. |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8730252
|
Huang J et al. |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:24117692
|
Molina-Infante J et al. |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20180787
|
Chacko Y and Holtmann GJ |
Helicobacter pylori eradication and weight gain: has it opened a Pandora's box? |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21679208
|
Murakami K et al. |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12390102
|
Zullo A et al. |
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15948808
|
Bühling A et al. |
Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552917
|
Hokari K et al. |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11552922
|
Dani R et al. |
Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594400
|
Harris A |
The importance of clarithromycin dose in the management of H. pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10594406
|
Harb AH et al. |
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for Helicobacter pylori eradication. |
2015 |
Aliment. Pharmacol. Ther. |
pmid:26011564
|
Lehmann FS et al. |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735923
|
Miwa H et al. |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735925
|
Spinzi GC et al. |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10735926
|
Graham DY et al. |
Furazolidone combination therapies for Helicobacter pylori infection in the United States. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651662
|
Wong BC et al. |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10651663
|
Harris AW et al. |
Eradication of Helicobacter pylori with lansoprazole and clarithromycin. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605863
|
Katelaris PH et al. |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7605864
|
Tomita T et al. |
Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11966543
|
Malfertheiner P et al. |
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12969088
|
Hassan C et al. |
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12969091
|
Sheu BS et al. |
Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:11856088
|
Miwa H et al. |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383502
|
Ducóns JA et al. |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383507
|
Calvet X et al. |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383508
|
Sieg A et al. |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10383519
|
Cestari R |
Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection. H. Pylori Lombardy Group. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9798804
|
Basset C et al. |
Helicobacter pylori infection: anything new should we know? |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15335411
|
Lionetti E et al. |
Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:17032283
|
Iijima K et al. |
Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15153171
|
Cammarota G et al. |
High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15043520
|
Spadaccini A et al. |
Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8899094
|
Fraser AG |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776748
|
Jung YS et al. |
Editorial: replacing standard proton pump inhibitors with vonoprazan may breathe new life into triple therapy for Helicobacter pylori-authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28776746
|
Sheu BS et al. |
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:15691303
|
Wong WM et al. |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection. |
2006 |
Aliment. Pharmacol. Ther. |
pmid:16423001
|
Savarino V et al. |
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9305478
|
Williams MP et al. |
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9305479
|
Janssen MJ et al. |
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11328254
|
Broutet N et al. |
Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12492738
|
Higuchi K et al. |
Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12492739
|
Coelho LG et al. |
Once-daily, low-cost, highly effective Helicobacter pylori treatment to family members of gastric cancer patients. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12492742
|
Gisbert JP et al. |
Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin. |
2005 |
Aliment. Pharmacol. Ther. |
pmid:16268980
|
Zullo A et al. |
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication? |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20518756
|
Laine L and Dhir V |
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12030957
|
Vallve M et al. |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12030958
|
Colin R |
Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial. |
2002 |
Aliment. Pharmacol. Ther. |
pmid:12030959
|